Risk Assessment of Perioperative Mortality After Pulmonary Resection for Primary Lung Cancer: the 30-day or 90-day Mortality

━━ Objective. Thirty-day mortality is adapted to the evaluation of perioperative mortality following pulmonary resection of primary lung cancer. However, whether 90-day mortality adequately evaluates perioperative mortality remains unknown. In this study, we analyzed the 30- and 90-day mortality following pulmonary resection of primary lung cancer at our institution. Methods. A total of 2207 pulmonary resections of primary lung cancer performed between 1996 and 2010 at Aichi Cancer Center Hospital were analyzed and divided into two groups of almost equal number: the early period (1070 patients treated between 1996 and 2004) and the late period (1137 patients treated between 2005 and 2010). Sixty-six and 34 postoperative deaths occurred within one year during the early and late periods, respectively. The causes of death (recurrence, bleeding, sudden death, respiratory failure and adverse events of chemotherapy) and 30- and 90-day mortality rates were investigated. Results. The 30- and 90-day mortality rates were 0.56% and 0.35%, respectively, during the early period and 0.75% and 0.79%, respectively, during the late period. Among the patients who died within one year after undergoing pulmonary resection, the postoperative survival of the patients with death due to recurrence (75 patients) and death due to bleeding or sudden death (seven patients) was >91 days and <30 days, respectively. The postoperative survival of the patients with death due to bleeding or sudden death (seven patients) was <30 days. The me-dian postoperative survival of the patients with respiratory failure was 67 days (range: 20-142 days) in the early period and 100 days (range: 47-149 days) in the late period. In the late period, adequately assessing perioperative mortality using 30-day mortality was difficult due to pulmonary complications. Conclusions. A risk assessment of perioperative mortality following pulmonary resection of primary lung cancer should be performed using 90- and 30-day mortality.

[1]  J. V. van Lanschot,et al.  Comparison of 30‐day, 90‐day and in‐hospital postoperative mortality for eight different cancer types , 2012, The British journal of surgery.

[2]  H. Sasaki,et al.  Post-operative acute exacerbation of pulmonary fibrosis in lung cancer patients undergoing lung resection. , 2012, Interactive cardiovascular and thoracic surgery.

[3]  D. Boffa,et al.  An analysis, systematic review, and meta-analysis of the perioperative mortality after neoadjuvant therapy and pneumonectomy for non-small cell lung cancer. , 2012, The Journal of thoracic and cardiovascular surgery.

[4]  Y. Kawabata,et al.  Survival after surgery for pathologic stage IA non-small cell lung cancer associated with idiopathic pulmonary fibrosis. , 2011, The Annals of thoracic surgery.

[5]  R. Cerfolio,et al.  The 30- versus 90-day operative mortality after pulmonary resection. , 2010, The Annals of thoracic surgery.

[6]  T. Higami,et al.  Is lung cancer resection indicated in patients with idiopathic pulmonary fibrosis? , 2008, The Journal of thoracic and cardiovascular surgery.

[7]  Richard J Stephens,et al.  Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  Kenji Suzuki,et al.  Recent results of postoperative mortality for surgical resections in lung cancer. , 2004, The Annals of thoracic surgery.

[9]  K. Yasuda,et al.  Thoracic and Cardiovascular Surgery in Japan during 2000 : Annual Report by The Japanese Association for Thoracic Surgery , 2002 .

[10]  J. Little Consistency of ASA grading. , 1995, Anaesthesia.